EUVIMEDEUVIMED entdecken
Open Access

Super‐Enhancer–Driven Syndecan‐4 Regulates Intercellular Communication in Hypoxic Pulmonary Hypertension

Xiaoying Wang iD, Xiangrui Zhu, Wei Huang iD, Zhaosi Wang, Jian Mei iD, Langlin Ou iD, Yunwei Chen, Cui Ma iD, Lixin Zhang iD

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.124.036757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Xiaoying Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy Harbin Medical University Daqing P. R. China. Hauptthemen laut MEDLINE: Syndecan-4, Pulmonary Artery, Cell Proliferation, Hypertension, Pulmonary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Unveiling pro‐proliferation genes involved in crosstalk between pulmonary artery endothelial cells and pulmonary artery smooth muscle cells (PASMCs) are important to improving the therapeutic outcome of pulmonary hypertension (PH). Although growing studies have shown that super‐enhancers (SEs) play a pivotal role in pathological and physiological processes, the SE‐associated genes in PH and their impact on PASMC proliferation remain largely unexplored. Methods and Results We used serotype 5 adenovirus‐associated virus to interfere with syndecan‐4 and constructed an SU5416 combined with hypoxia–PH model. Chromatin immunoprecipitation sequencing analysis, chromatin immunoprecipitation quantitative polymerase chain reaction, and bioinformatics were used to confirm early growth response 1 was involved in regulating syndecan‐4‐associated SE in PASMCs. The effects of syndecan‐4 and its underlying mechanisms were subsequently elucidated using Western blot, coimmunoprecipitation, and cell coculture assays. Herein, we identified a novel SE‐associated gene, syndecan‐4, in hypoxia‐exposed PASMCs. Syndecan‐4 was transcriptionally driven by early growth response 1 via an SE and was significantly overexpressed in hypoxic PASMCs and plasma from patients with PH. Mechanism studies revealed that syndecan‐4 induces PASMC proliferation by interacting and regulating protein kinase C α ubiquitination. In addition, syndecan‐4 was enriched in exosomes secreted from hypoxic PASMCs, which subsequently transported and led to pulmonary artery endothelial cell dysfunction. Syndecan‐4 inhibition in hypoxia by serotype 5 adenovirus‐associated virus treatment attenuated the pulmonary artery remodeling and development of PH in vivo.

Conclusions

Taken together, our results demonstrate that an SE‐driven syndecan‐4 modulates crosstalk of PASMCs and pulmonary artery endothelial cells and promotes vascular remodeling via the protein kinase C α and exosome pathway, thus providing potential targets for the early diagnosis and treatment of hypoxic PH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Syndecan-4Pulmonary ArteryCell ProliferationHypertension, PulmonaryMyocytes, Smooth MuscleMuscle, Smooth, VascularCell CommunicationAnimalsHumansEndothelial CellsCells, CulturedHypoxiaDisease Models, AnimalSignal TransductionMaleMiceRatsVascular RemodelingCell HypoxiaIndolesPyrroles

Stichwörter der Autor:innen

exosomeproliferationpulmonary hypertensionsuper‐enhancersyndecan‐4

Substanzen

Syndecan-4SDC4 protein, humanSemaxinibIndolesPyrroles

Autor:innen und Institutionen

  • College of Pharmacy Harbin Medical University Daqing P. R. China.
  • Central Laboratory of Harbin Medical University Daqing P. R. China.
  • College of Medical Laboratory Science and Technology Harbin Medical University Daqing P. R. China.
  • Cardiovascular Medicine The First Affiliated Hospital of Chongqing Medical University Chongqing P. R. China.
  • Institute of Cardiovascular Diseases, Xiamen Cardiovascular Hospital, School of Medicine Xiamen University Xiamen P. R. China.

ORCID-Profile: Xiaoying Wang, Wei Huang, Jian Mei, Langlin Ou, Cui Ma, Lixin Zhang

Zitieren

APA

Wang, X., Zhu, X., Huang, W., Wang, Z., Mei, J., Ou, L., Chen, Y., Ma, C., & Zhang, L. (2024). Super‐Enhancer–Driven Syndecan‐4 Regulates Intercellular Communication in Hypoxic Pulmonary Hypertension. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036757

Vancouver

Wang X, Zhu X, Huang W, Wang Z, Mei J, Ou L, et al. Super‐Enhancer–Driven Syndecan‐4 Regulates Intercellular Communication in Hypoxic Pulmonary Hypertension. Journal of the American Heart Association. 2024. doi:10.1161/jaha.124.036757

BibTeX
@article{Wang2024,
  author = {Wang, Xiaoying and Zhu, Xiangrui and Huang, Wei and Wang, Zhaosi and Mei, Jian and Ou, Langlin and Chen, Yunwei and Ma, Cui and Zhang, Lixin},
  title = {Super‐Enhancer–Driven Syndecan‐4 Regulates Intercellular Communication in Hypoxic Pulmonary Hypertension},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.124.036757}
}
Kostenlos starten →